BL is a middle ag ed male with dysthymia and severe recurren t m ajor d epression, and a negative past medical history. Hi s illness had partially responded to fluox etine, desipramine, ph en elzine and paroxetine; how ever, his chro nic low-grade depression and almost consta n t suicidal preoccupation never resolved . H e received ECT, also with an initial good response, but lat er relap sed with a re turn of his episod ic seve re depression. Subsequ ent trials of bupropi on wit h liothyro nin e au gmentation, venlafaxine, and a combina tion of se rt raline , nortriptylin e a nd lithium a ll failed .
Sin ce th e initial fluox etine trial was on ly two weeks time in len gth, it was restarted without significant improvement. M ethylphenidate was thus added and titrat ed to a dos e of 10 mg bid . On this regimen, BL expe rie nce d improve men t in e ne rgy level and d emonstrated a brighter affect. Again, however, his low-grad e depression and sui cidal preoccupation continue d. Bupropion, was th en start ed and th en titrat ed to a maximum dos e of 100 mg bid . Th e tripl e th erap y was we lltol erated , and brought about significant clinical improvem ent. His e ne rgy level improved further, and his dysphporia, sleep disturbance, anh edonia a nd suic ida l ideation gradually resolved. At two-month follow-up, th es e improvem en ts were sustained. Most importantly, his sui cidal ideation remained markedl y decr eased. H e continues to do well on this triple regimen of bupropion 100 mg bid , fluoxet ine 20 mg, and m ethylphenidate 10 mg bid , without significa nt side-e ffec ts . This patient's experie nce suggests that in case s of severe dep ression th a t fails or partially responds to monotherapy, a ug me n tatio n th erapy a nd even ECT, th e tripl e-therapy d escribed may bring a bout clinical improvem ent. T his patient's sustain ed response is rath er e ncou rag ing, give n hi s lon g histo ry of severe a nd frequ ently recurrent illn es s. It is postulated th at , via this regimen, level s of ce nt ral serotonin, norepin ephrine a nd dopamine may be more effec t ively increased , t hereby exe r t ing it s adde d th erapeutic benefit. It is also our opinion th at this form of t rip le th erapy repres ents an addition al a ug me n ta t ion st ra tegy whi ch may be useful in cas es like th e on e described , or wh en a co m bina t ion of SRI a nd eit he r me t hylphenidate or bupropion fails to bring about a full clinical response. C lose r exam ination involving larger numbers of su ch patients is st ill need ed in o rde r to subs ta ntiate th is posit ion.
